FTH
Faeth Therapeutics, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$589.56M
P/E Ratio
—
EPS
$-142.72
Beta
-0.23
52W High
$36.76
52W Low
$6.33
50-Day MA
$21.52
200-Day MA
$16.79
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Faeth Therapeutics, Inc.
None
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-185.51M |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -95.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-102.43 |
| Price-to-Book | 1.26 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.36 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $25.78M |
| Float | $1.18M |
| % Insiders | 1.45% |
| % Institutions | 25.66% |
Historical Volatility
HV 10-Day
142.84%
HV 20-Day
176.34%
HV 30-Day
164.22%
HV 60-Day
129.19%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($54.50 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 6/30/2026